Back to Rankings

ATRA

Atara BiotherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ATRA vs peer average
95/100
ATRA vs. peer average (A vs. D)
Grade spread
B 1 · D 3 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ELUT is the first available peer comparator.

Loose peer only: same-sector micro-cap comparison helps frame capital-markets risk and event volatility, but does not provide a clean read-through for tab-cel regulatory odds.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerELUTElutia
ATRA
Atara Biotherapeutics
ELUT
Elutia
Grade
A
F
Momentum
99
9
Value
57
41
Sentiment
35
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ELUT

ATRA / ELUT
Grade Position
Above peers
ATRA vs. peer average (A vs. D)
95/100
Momentum
99
ATRA
Value
57
ATRA
Sentiment
35
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ATRA
1
ELUT
ELUT
F
20/100
+4
2
TLPH
TLPH
D
40/100
+3
3
XLO
XLO
D
40/100
+3
4
ICCC
ImmuCell Corp Common
F
20/100
+4
5
RNTX
Rein Therapeutics Inc Common
F
20/100
+4
ELUT is the first peer returned for this comparison set.